Now that they have the single drug baseline it should be simple enough to a combo trial and compare results. Similarly for large number of cancers, which is how I understand our “all comers any cancer” trial. So any improvements are easily identifiable.
Now that they have the single drug baseline it should be simple...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.69 |
Change
0.140(9.03%) |
Mkt cap ! $277.8M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.75 | $1.61 | $536.7K | 320.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1200 | $1.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 1500 | 1 |
View Market Depth
| Last trade - 14.08pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.68 |
Change
0.140 ( 9.26 %) |
||||
| Open | High | Low | Volume | ||
| $1.64 | $1.73 | $1.63 | 28949 | ||
| Last updated 14.33pm 14/05/2024 ? | |||||
| RAC (ASX) Chart |